| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/14/1993 | CN1074228A Microcrystalline celluiose spheronization composition |
| 07/14/1993 | CN1074224A Carboxylic ethylene polymer for showing newtonian viscosity |
| 07/14/1993 | CN1074220A Cell-free ciliary neurotrophic factor/receptor complex |
| 07/14/1993 | CN1074135A Adjuvants |
| 07/14/1993 | CN1074134A Medicinal granulating composite and its preparation method |
| 07/13/1993 | US5227474 Bifunctional chelating agents |
| 07/13/1993 | US5227374 Sodium bicarbonate |
| 07/13/1993 | US5227373 Lyophilized ifosfamide compositions |
| 07/13/1993 | US5227372 Complexing with glucan sulfate |
| 07/13/1993 | US5227169 Sorbitan esters as skin permeation enhancers |
| 07/13/1993 | US5227161 Method to clean and disinfect pathogens on the epidermis by applying a composition containing peroxidase, iodide compound and surfactant |
| 07/13/1993 | US5227152 Radiopharmaceutical bacteriostats |
| 07/13/1993 | CA1320192C Pharmaceutical compositions |
| 07/13/1993 | CA1320134C Dissolved composition of [benzo-1,2,4-thiadiazine]-1, 1-dioxide |
| 07/13/1993 | CA1320131C Aqueous pharmaceutical preparation containing 11.beta.-hydroxy steroids |
| 07/13/1993 | CA1320044C Matrix for release of active ingredients |
| 07/08/1993 | WO1993013417A1 Receptor/oncogene growth factor system in breast cancer |
| 07/08/1993 | WO1993013138A1 A method for preparing enteric-coated oral drugs containing acid-unstable compounds |
| 07/08/1993 | WO1993012818A1 Pharmaceutical preparation for topical application |
| 07/08/1993 | WO1993012814A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 07/08/1993 | WO1993012812A1 A stabilized pharmaceutical formulation comprising growth hormone and histidine |
| 07/08/1993 | WO1993012811A1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine |
| 07/08/1993 | WO1993012802A1 Biomedical water soluble hydrophilic polyurethane polymers and method of use thereof |
| 07/08/1993 | WO1993012797A1 Pharmaceutical compositions containing natural progesterone having a high biological availability |
| 07/08/1993 | WO1993012783A1 Oleaginous ointment |
| 07/08/1993 | WO1993012768A1 Microcrystalline cellulose spheronization composition |
| 07/08/1993 | WO1993012765A1 A controlled release drug dispersion delivery device |
| 07/08/1993 | WO1993012756A2 Transfection of lung via aerosolized transgene delivery |
| 07/08/1993 | WO1993012744A1 Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems |
| 07/08/1993 | WO1993010743A3 Controlled use of polyether-substituted tumor agents in diagnosis and therapy |
| 07/08/1993 | WO1992008494A3 Targeting radioactive immunoreagents |
| 07/08/1993 | CA2126686A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 07/08/1993 | CA2126214A1 Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems |
| 07/08/1993 | CA2125856A1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine |
| 07/07/1993 | EP0550385A1 Oral pharmaceutical compositions containing derivatives of methane-diphosphonic acid and 18-crown-6 ethers |
| 07/07/1993 | EP0550035A2 Composition of stabilized fibroblast growth factor |
| 07/07/1993 | EP0550031A1 Aerosol compositions |
| 07/07/1993 | EP0549975A1 Drug and fodder premixes |
| 07/07/1993 | EP0549967A1 Polymers and oligomers of bile-acids, process for their production and their use as medicines |
| 07/07/1993 | EP0549702A1 Uses of recombinant colony stimulating factor-1 |
| 07/07/1993 | EP0549592A1 Stabilized retinoid-containing skin care compositions |
| 07/07/1993 | EP0536255A4 Ophthalmic suspensions |
| 07/07/1993 | CN1073889A Multile emulsions and methods of preparation |
| 07/07/1993 | CN1073880A Contrast agents for ultrasound imaging |
| 07/06/1993 | US5225541 Composition containing CEA/NCA-specific monoclonal antibody XMMBR-B14 conjugated to a detectable moiety and a kit containing the antibody |
| 07/06/1993 | US5225347 Therapeutic ribozyme compositions and expression vectors |
| 07/06/1993 | US5225282 Biodegradable magnetic microcluster comprising non-magnetic metal or metal oxide particles coated with a functionalized polymer |
| 07/06/1993 | US5225238 Method for coating active principles with a ph-sensitive polymer |
| 07/06/1993 | US5225212 Microreservoir liposome composition and method |
| 07/06/1993 | US5225206 Sustained-release pranoprofen preparation |
| 07/06/1993 | US5225204 Stable dosage of levothyroxine sodium and process of production |
| 07/06/1993 | US5225198 Drug delivery |
| 07/06/1993 | US5225189 Gelation by specific mixing sequence of carbomer, water, alcohol, amine, and glycol |
| 07/06/1993 | US5225182 For specific organ delivery |
| 07/06/1993 | CA1319888C Process for the preparation of an antipsoriatic pharmaceutical composition |
| 07/06/1993 | CA1319849C Oxygen removal |
| 07/01/1993 | CA2086492A1 Medicinal aerosol formulation |
| 06/30/1993 | EP0549420A1 Dry, porous galenic form made of plants, method to prepare it and its applications |
| 06/30/1993 | EP0549331A1 Controlled release drug dispersion delivery device |
| 06/30/1993 | EP0549074A1 Adjuvants |
| 06/30/1993 | EP0548867A2 Soluble stem cell factor (SFC)-receptor |
| 06/30/1993 | EP0548794A2 Polyaspartamide derivative as adsorbent for bile acids, polyaspartamide loaded with bile acids and preparation and use as a drug |
| 06/30/1993 | EP0548635A1 Pharmaceutical compositions of roxindol or carmoxirol with pregelatinized starch |
| 06/30/1993 | EP0548558A2 Compositions containing surfactants as potentiating agents for the treatment of mammalian diseases |
| 06/30/1993 | EP0548448A1 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| 06/30/1993 | EP0548344A1 Collagen composites for controlled drug release |
| 06/30/1993 | EP0548238A1 Non-aqueous liquid oral suspensions |
| 06/30/1993 | EP0548210A1 Liposomes |
| 06/30/1993 | EP0548157A1 Use of particulate agents |
| 06/30/1993 | EP0548088A1 Method of producing semi-solid preparations containing micro-particulate substances |
| 06/30/1993 | EP0455631B1 Preparation containing salicylic acid for treating desquamative skin diseases |
| 06/29/1993 | US5223515 Injectable solution containing a pyridyl methylsulfinylbenzimidazole |
| 06/29/1993 | US5223410 Method for production of antibodies utilizing an antigen-free animal |
| 06/29/1993 | US5223271 Lithium treatment |
| 06/29/1993 | US5223268 Improved bioavailability |
| 06/29/1993 | US5223267 Analgesic compositions |
| 06/29/1993 | US5223251 Containing microporous cellulse powder |
| 06/29/1993 | US5223242 In situ imaging or therapy method |
| 06/29/1993 | CA1319615C Method of preparing a solid composition of lactulose, and composition so obtained |
| 06/29/1993 | CA1319614C Delivery vehicles with amphiphile-associated active ingredient |
| 06/29/1993 | CA1319613C Penetration enhancers for transdermal delivery of systemic agents |
| 06/29/1993 | CA1319468C Polymer blends having reverse phase morphology for controlled delivery of bioactive agents |
| 06/24/1993 | WO1993012240A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
| 06/24/1993 | WO1993012220A1 RECOMBINANT AND CHIMERIC ANTIBODIES TO c-erbB-2 |
| 06/24/1993 | WO1993012145A1 Pva or peg conjugates of peptides for epitope-specific immunosuppression |
| 06/24/1993 | WO1993012142A1 Cytokines with an unpaired cysteine residue and conjugates thereof |
| 06/24/1993 | WO1993011868A1 Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of making and using them |
| 06/24/1993 | WO1993011799A1 Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation |
| 06/24/1993 | WO1993011798A1 Improved formulations with hydrophobic permeation enhancers |
| 06/24/1993 | WO1993011796A1 Further improvements relating to the radiolabelling of proteins |
| 06/24/1993 | WO1993011788A1 Gonadotropin containing pharmaceutical compositions with sucrose stabilizer |
| 06/24/1993 | WO1993011785A1 Stabilized parathyroid hormone composition |
| 06/24/1993 | WO1993011777A1 Amphotericin b composition with enhanced antifungal activity |
| 06/24/1993 | WO1993011775A1 Transdermal azidothymidine |
| 06/24/1993 | WO1993011772A1 Glycosylated steroid derivatives for transport across biological membranes and process for making same |
| 06/24/1993 | WO1993011763A1 Use of cytochalasins for inhibiting viral replication |
| 06/24/1993 | WO1993011752A1 Defoaming composition |
| 06/24/1993 | WO1993011750A1 Ulcer prevention and treatment composition and method |
| 06/24/1993 | WO1993011749A1 A process for the preparation of a solid dispersion |
| 06/24/1993 | WO1993011747A1 Suspension aerosol formulations |